Testosterone Replacement Therapy — Gel

ALPHALABS's testosterone gel programme delivers medically supervised hormonal optimisation for men who prefer self-application at home rather than clinic injections — ideal for frequent travellers, those based outside Prague or clients with needle sensitivity. The physician prescribes a transdermal testosterone gel applied to the skin daily, combined with monthly clinic visits for blood monitoring and therapy adjustment under the supervision of MUDr. Marek Dvořák. Annual membership brings the monthly cost down from 5,990 Kč to 4,499 Kč.

Testosterone gel therapy at ALPHALABS offers an alternative delivery route for men who require testosterone replacement but find clinic-based injections incompatible with their lifestyle or personal preferences. The transdermal gel formulation is absorbed through the skin and enters the bloodstream steadily throughout the day, producing more stable plasma testosterone levels compared to the peak-and-trough pharmacokinetics of longer-acting depot injections. The programme begins with the same entry blood test and physician consultation used for the injection pathway. Once the physician confirms that TRT is clinically appropriate and discusses delivery preferences, the gel protocol is initiated. Application instructions are explained in detail at the first supervised session: the gel is applied once daily to clean, dry skin on the shoulders, upper arms or abdomen — areas of reliable absorption — and allowed to dry before contact with clothing or another person. The physician sets the starting dose based on baseline testosterone levels and symptom severity. Monthly clinic visits remain mandatory throughout the programme. At each check-up, the physician draws blood to assess total and free testosterone, oestradiol, complete blood count, liver enzymes, kidney function, PSA and lipid profile. Dose adjustments are made based on results: if levels are sub-therapeutic, gel quantity or application frequency increases; if oestradiol rises disproportionately (from aromatisation), adjunct management is considered. This monitoring cadence is the same as for the injection protocol — the delivery mechanism differs, not the clinical rigour. The gel format is well suited to men who travel internationally for work (the product is portable and carries no sharps), those who live more than a commuting distance from Prague or Brno and cannot attend frequently, and men who have trypanophobia (needle phobia). The physician is transparent about the relative tradeoffs: the gel is slightly less pharmacologically potent per milligram than depot injection, absorption can vary with skin type and sweating, and consistent daily self-application discipline is required for stable results. Skin-to-skin transfer is the primary safety consideration: gel must be dry before contact with a partner or children, and application sites should be covered after drying. This is reviewed at every consultation. Annual membership at 4,499 Kč/month (versus 5,990 Kč monthly) rewards long-term commitment and reflects the clinic's view that hormonal optimisation is a sustained programme, not a short-term intervention.